Eli Lilly's New Drug Could Lead To Alzheimer's Cure
Eli Lilly is debuting solanezumab, its new drug designed to cure Alzheimer's. But will the drug fare better than past trials have foreshadowed?By Ryan Biek | July 22, 2015
On Wednesday, a new drug is being unveiled that scientists say has the potential to cure Alzheimer's, a disease that so far has only had its symptoms treated.
The drug is said to be an antibody to amyloid plaques, a cause of the disease. These plaques are sticky proteins that bind together, blocking brain cells from communicating with one another.